In this blog we recap our Early Detection & Screening (ED&S) Working Group’s summer seminar “Performance with Purpose: Metrics that Inform Clinical and Public Health Decisions,” which took place virtually on August 20 at 11:00 AM ET.

Featured speaker:

Peter Sasieni, PhD - Professor of Cancer Epidemiology and joint lead of the Centre for Cancer Screening, Prevention and Early Diagnosis

Following his talk, Dr. Sasieni was joined by two exceptional panelists for a dynamic discussion:

Donna Roscoe, PhD - Consultant and former Acting Director, Division of Molecular Genetics and Pathology (DMGP) in the Office of In Vitro Diagnostics at CDRH

Jody Hoyos, MHA - CEO of the Prevent Cancer Foundation

At the 2024 annual meeting of the American Association for Cancer Research (AACR), BLOODPAC’s Early Detection and Screening Working Group (ED&S WG) hosted a session focusing on cancer risk and risk assessment for liquid biopsy-based single- and multi-cancer screening.

In this article, we explore the identification, characterization, analysis, and clinical applications of circulating tumor cells in blood-based liquid biopsy for cancer management.